These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35581502)

  • 21. Controversy over radioiodine ablation in thyroid cancer: who benefits?
    Yoo DC; Noto RB; Mazzaglia PJ
    Surg Clin North Am; 2014 Jun; 94(3):573-86. PubMed ID: 24857577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioiodine and thyroid cancer: some questions, controversies, and considerations.
    Daniels GH
    Endocr Pract; 2001; 7(4):320-3. PubMed ID: 11497485
    [No Abstract]   [Full Text] [Related]  

  • 23. Radioiodine in treatment of metastatic thyroid cancer.
    Dewan SS; Sharma SM; Ganatra RD
    Int J Nucl Med Biol; 1979; 6(4):213-4. PubMed ID: 528148
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiotherapy: radioiodine in thyroid cancer-how to minimize side effects.
    Reiners C; Luster M
    Nat Rev Clin Oncol; 2012 Jun; 9(8):432-4. PubMed ID: 22710337
    [No Abstract]   [Full Text] [Related]  

  • 25. Controversies on the Use of Radioiodine in Thyroid Cancer: We Need More and Better Data.
    Pryma DA
    J Nucl Med; 2018 Aug; 59(8):1184-1186. PubMed ID: 29934408
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved planning of radioiodine therapy for thyroid cancer.
    Medvedec M
    J Nucl Med; 2002 May; 43(5):714; author reply 714. PubMed ID: 11994536
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.
    Scott E; Learoyd D; Clifton-Bligh RJ
    Future Oncol; 2016 Nov; 12(22):2603-2613. PubMed ID: 27387641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies.
    Pryma DA; Mandel SJ
    J Nucl Med; 2014 Sep; 55(9):1485-91. PubMed ID: 25134528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risks and benefits of radioiodine therapy for thyroid carcinoma remain somewhat undifferentiated.
    Haugen BR
    Thyroid; 2000 Nov; 10(11):971-3. PubMed ID: 11128724
    [No Abstract]   [Full Text] [Related]  

  • 30. Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation.
    Haugen BR
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3665-7. PubMed ID: 15292284
    [No Abstract]   [Full Text] [Related]  

  • 31. New therapeutic approaches for metastatic thyroid carcinoma.
    Baudin E; Schlumberger M
    Lancet Oncol; 2007 Feb; 8(2):148-56. PubMed ID: 17267329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
    Schlumberger M; Catargi B; Borget I; Deandreis D; Zerdoud S; Bridji B; Bardet S; Leenhardt L; Bastie D; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Bonichon F; Dejax C; Toubert ME; Leboulleux S; Ricard M; Benhamou E;
    N Engl J Med; 2012 May; 366(18):1663-73. PubMed ID: 22551127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted therapy in radioiodine refractory thyroid cancer.
    Pacini F; Brilli L; Marchisotta S
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.
    Hadjieva T
    Radiobiol Radiother (Berl); 1985; 26(6):819-23. PubMed ID: 4095270
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH].
    Rosário PW
    Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):338-40. PubMed ID: 22911289
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical uses of recombinant human thyrotropin.
    Gourgiotis L; Skarulis MC
    Expert Opin Pharmacother; 2004 Dec; 5(12):2503-14. PubMed ID: 15571468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advances.
    Schlumberger M; Sherman SI
    Thyroid; 2009 Dec; 19(12):1393-400. PubMed ID: 20001721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioiodine and thyroid carcinoma].
    Valdés M; Pineda G
    Rev Med Chil; 1977 Sep; 105(9):603-8. PubMed ID: 757828
    [No Abstract]   [Full Text] [Related]  

  • 40. [Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out].
    Koch W; Knesewitsch P; Tatsch K; Hahn K
    Nuklearmedizin; 2003 Feb; 42(1):10-4. PubMed ID: 12601448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.